Denis Ribon

Denis Ribon serves as the Chairman and Managing Partner at ARCHIMED since April 2014, focusing on impacting healthcare. In addition, Denis holds multiple Board Director positions at several organizations, including Groupe CARSO, SUANFARMA, Prollenium, ImaBiotech, NAMSA, ActiGraph, and Polyplus-transfection S.A., contributing expertise in areas such as pharmaceutical purity testing, active pharmaceutical ingredient manufacturing, dermal fillers, biotechnology, medical device testing, drug trial monitoring, and gene therapy solutions. Previous Board Director experience includes Provepharm Life Solutions and Citieffe Holding. Denis Ribon's educational background includes a Veterinary degree from VetAgro Sup, an MBA from HEC Paris, and a Baccalauréat in Mathematics from Sainte-Marie Lyon.